West Pharmaceutical Services, Inc.
WSTStock
$362.44+62.41%52W
Market Cap$24.99B
P/E50.63x
Div yield0.33%
Beta1.13
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)19.47%
Price vs S&P 500 (4W)8.33%
VGM Score54.97
Market Capitalization$24.99B
P/E Ratio (Annual)50.63x
Indicated Dividend Yield (Annual)0.33%
Earnings Surprise History
Q1 262.13est. 1.69
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.04
4.04
4.09
4.14
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
| BAXBaxter International Inc. | B | F | C | $23.35 |
About
West Pharmaceutical Services supplies critical packaging and delivery systems to the pharmaceutical, biotechnology, and generic drug industries. Its products include elastomer-based packaging components, nonglass containment solutions, and auto-injectors for biologics, GLP-1 agonists, and small-molecule drugs. The company derives approximately 80% of revenue from proprietary products and 20% from contract manufacturing, with 55% of revenue from international markets.